Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer

This publication has 16 references indexed in Scilit:

• A report of RTOG 8206: A phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Strontium-89 chloride for pain palliation in prostatic skeletal malignancy
  The British Journal of Radiology, 1991
• A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
  European Journal of Cancer and Clinical Oncology, 1991
• The Palliation of Osseous Metastasis with 32p or⁸⁹Sr Compared with External Beam and Hemibody Irradiation: A Historical Perspective
  Cancer Investigation, 1989
• Carcinoma of the prostate: pathology, staging, and treatment
  Current Problems in Cancer, 1988
• Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysis
  The British Journal of Radiology, 1987
• Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate
  European Journal of Nuclear Medicine and Molecular Imaging, 1986
• Comparison of 32P Therapy and Sequential Hemibody Irradiation (HBI) for Bony Metastases as Methods of Whole Body Irradiation
  American Journal of Clinical Oncology, 1986
• Half body radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1976
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958